National News

Drug that could tackle Omicron variant approved by UK regulators

today2 December 2021 1

share close

Drug that could tackle Omicron variant approved by UK regulators

A drug treatment which, the makers say, works against the new Omicron variant of Covid-19 has been approved by UK regulators.

Xevudy (sotrovimab), made by pharmaceutical giant GlaxoSmithKline (GSK), has been found to cut hospital admission and death by 79% in those at risk.

The monoclonal antibody has been authorised by the Medicines and Healthcare products Regulatory Agency for people with mild to moderate Covid-19 who are at high risk of developing severe disease.

It comes as GSK and Vir Biotechnology said preclinical data shows the drug “retains activity against key mutations of the new Omicron Sars-CoV-2 variant”.

The UK Government has ordered around 100,000 doses of the drug.

Published: by Radio NewsHub

Written by: ES1

Rate it

Previous post

National News

Government secures 114 million jabs for future booster campaigns

Covid-19 vaccines for potential booster campaigns in the next two years have been secured by ministers. Some scientists have suggested that Covid-19 will need to be kept at bay with repeated vaccination campaigns while others have said it is too early to tell whether annual boosters will be needed. While there is uncertainty over the need for future campaigns, the Government announced that it has signed deals for 114 million […]

today2 December 2021 2

Similar posts

Post comments (0)

Leave a reply